CoChat

Emerging treatment options for type 2 diabetes

Open access
Piya, Milan K., Tahrani, Abd A., Barnett, Anthony H. · 2010 · British Journal of Clinical Pharmacology
Cited by 72

The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.

Abstract

Type 2 diabetes mellitus (T2DM) is rapidly increasing in prevalence and is a major public health problem. It is a progressive disease which commonly requires multiple pharmacotherapy. Current options for treatment may have undesirable side effects (particularly weight gain and hypoglycaemia) and contraindications, and little effect on disease progression. Incretin based therapy is one of several newer therapies to improve glycaemia and is available in two different forms, dipeptidyl peptidase‐4 (DPP‐4) inhibitors and glucagon‐like peptide‐1 (GLP‐1) agonists. Use of these agents results in a ‘glucose‐dependant’ increase in insulin secretion and glucagon suppression resulting in improved glycaemia with low incidence of hypoglycaemia. DPP‐4 inhibitors are oral drugs which are weight neutral, while GLP‐1 agonists are injected subcutaneously and help promote weight loss while improving glycaemia. GLP‐1 agonists have also been shown to increase beta cell mass in rat models. Bariatric surgery is another option for the obese patient with T2DM, with blood glucose normalizing in over half of the patients following surgery. Other therapies in development for the treatment of T2DM include sodium‐glucose transporter 2 (SGLT‐2) inhibitors, glucagon receptor antagonists, glucokinase activators and sirtuins. In this article, we will review the various existing and emerging treatment options for T2DM.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1365-2125.2010.03711.x

Cites

48 of 48 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 48 references

Cited by

See all 72

Metadata

Authors
Piya, M. K., Tahrani, A. A., & Barnett, A. H.
Venue
British Journal of Clinical Pharmacology
Publisher
Wiley
Published
2010-05-27
Volume
70
Issue
5
Pages
631-644
ISSN
  • 0306-5251 (ISSN-L)
  • 1365-2125
OpenAlex
W1931319935
Cited by
72
References
48
FWCI
4.40
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Emerging treatment options for type 2 diabetes. https://app.cochat.ai/papers/10.1111/j.1365-2125.2010.03711.x
The paper
Piya, M. K., Tahrani, A. A., & Barnett, A. H. (2010). Emerging treatment options for type 2 diabetes. British Journal of Clinical Pharmacology. https://doi.org/10.1111/j.1365-2125.2010.03711.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.